<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Maia N</submitter><funding>National Eye Institute</funding><funding>NEI NIH HHS</funding><funding>Foundation for Science and Technology (FCT)</funding><funding>NHGRI NIH HHS</funding><funding>Broad Institute</funding><funding>National Human Genome Research Institute</funding><pagination>135-143</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10092556</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>191(1)</volume><pubmed_abstract>We describe the phenotype of 22 male patients (20 probands) carrying a hemizygous missense variant in MED12. The phenotypic spectrum is very broad ranging from nonspecific intellectual disability (ID) to the three well-known syndromes: Opitz-Kaveggia syndrome, Lujan-Fryns syndrome, or Ohdo syndrome. The identified variants were randomly distributed throughout the gene (p = 0.993, χ&lt;sup>2&lt;/sup> test), but mostly outside the functional domains (p = 0.004; χ&lt;sup>2&lt;/sup> test). Statistical analyses did not show a correlation between the MED12-related phenotypes and the locations of the variants (p = 0.295; Pearson correlation), nor the protein domain involved (p = 0.422; Pearson correlation). In conclusion, establishing a genotype-phenotype correlation in MED12-related diseases remains challen</pubmed_abstract><journal>American journal of medical genetics. Part A</journal><pubmed_title>Missense MED12 variants in 22 males with intellectual disability: From nonspecific symptoms to complete syndromes.</pubmed_title><pmcid>PMC10092556</pmcid><funding_grant_id>UIDB/00215/2020 UIDP/00215/2020 LA/P/0064/2020</funding_grant_id><funding_grant_id>R01 HG009141</funding_grant_id><funding_grant_id>UM1 HG008900</funding_grant_id><pubmed_authors>Santos R</pubmed_authors><pubmed_authors>Terhal P</pubmed_authors><pubmed_authors>Ibarluzea N</pubmed_authors><pubmed_authors>Kleefstra T</pubmed_authors><pubmed_authors>Yeh RC</pubmed_authors><pubmed_authors>Koboldt DC</pubmed_authors><pubmed_authors>Valenzuela I</pubmed_authors><pubmed_authors>Karteszi J</pubmed_authors><pubmed_authors>Marcelis CLM</pubmed_authors><pubmed_authors>Mori M</pubmed_authors><pubmed_authors>Gabau Vila E</pubmed_authors><pubmed_authors>Soares G</pubmed_authors><pubmed_authors>Jorge P</pubmed_authors><pubmed_authors>Maia N</pubmed_authors><pubmed_authors>Marques I</pubmed_authors><pubmed_authors>Elting MW</pubmed_authors><pubmed_authors>Neil JE</pubmed_authors><pubmed_authors>Cueto-Gonzalez AM</pubmed_authors><pubmed_authors>Misra-Isrie M</pubmed_authors><pubmed_authors>Csaszar A</pubmed_authors><pubmed_authors>Bessenyei B</pubmed_authors><pubmed_authors>Guitart M</pubmed_authors><pubmed_authors>Keski-Filppula R</pubmed_authors><pubmed_authors>Lasa-Aranzasti A</pubmed_authors><pubmed_authors>Abu-Libde B</pubmed_authors><pubmed_authors>Chhouk BH</pubmed_authors><pubmed_authors>de Brouwer APM</pubmed_authors><pubmed_authors>van Hagen JM</pubmed_authors><pubmed_authors>Hickey S</pubmed_authors><pubmed_authors>Lehman A</pubmed_authors><pubmed_authors>van Bokhoven H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Missense MED12 variants in 22 males with intellectual disability: From nonspecific symptoms to complete syndromes.</name><description>We describe the phenotype of 22 male patients (20 probands) carrying a hemizygous missense variant in MED12. The phenotypic spectrum is very broad ranging from nonspecific intellectual disability (ID) to the three well-known syndromes: Opitz-Kaveggia syndrome, Lujan-Fryns syndrome, or Ohdo syndrome. The identified variants were randomly distributed throughout the gene (p = 0.993, χ&lt;sup>2&lt;/sup> test), but mostly outside the functional domains (p = 0.004; χ&lt;sup>2&lt;/sup> test). Statistical analyses did not show a correlation between the MED12-related phenotypes and the locations of the variants (p = 0.295; Pearson correlation), nor the protein domain involved (p = 0.422; Pearson correlation). In conclusion, establishing a genotype-phenotype correlation in MED12-related diseases remains challen</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jan</publication><modification>2026-04-08T14:04:13.67Z</modification><creation>2025-04-07T05:08:03.525Z</creation></dates><accession>S-EPMC10092556</accession><cross_references><pubmed>36271811</pubmed><doi>10.1002/ajmg.a.63004</doi></cross_references></HashMap>